Tag: Covid-19
Browse our exclusive articles!
End-State Realities: How Wars Begin Is Not How They End —Emphasising that strategic exit planning is crucial for victory or defeat, not just the...
Wars are often studied in terms of how they...
Beyond Partisanship: Reclaiming the Primacy of National Interest
In any vibrant democracy, diversity of thought is both...
Regional Retaliation: The Gulf as the Second Battlefield — Infrastructure Vulnerability, Desalination Dependency, and the Russia–China Strategic Anchor – Part 9
In the previous part of this series, we explored...
Strategic Silence, Tactical Misinterpretation: How India Stayed Silent During a Key West Asian Crisis
The recent Iran conflict and its uneasy ceasefire will...
COVID-19 vaccines in clinical trials but scientists clueless on antibody
Using X-ray crystallography, the team imaged two antibodies attached to their target site on SARS-CoV-2 and the resulting atomic-structure details of this interaction might potentially help the vaccine designers.
US withdrawal from WHO draws scepticism and criticisms
The US contributes between $107 to $119 million in assessed contributions and an additional $102 - $401 million per year. The WHO’s total budget per year is $2.4 billion.
PFRDA allows Upgrade or Downgrade of Atal Pension Yojana Account round the year
Earlier, this provision was available only during the month of April every year. Effective from July 1, this is with a view to make the Atal Pension Yojana more attractive for its 2.28 crore subscribers.
Use Clause 92 of the Indian Patent Act, break Remdesivir monopoly, issue Compulsory License
India is one of the largest generic drug manufacturers in the world and there should be no reason why Remdesivir and other COVID-19 drugs cannot be made available rapidly and at affordable prices to India and the world.
My Doctor wife shows how to beat COVID 19 like a boss
Covid19 was declared a pandemic in the first quarter of 2020. Everyone’s lives changed. We, the doctors who were looked down upon by the...
